Alok K. Gupta

Alok K. Gupta

Auto-generated profile, based on publicly available information

Alok K. Gupta

Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Obesity
Verified
Journal Article
Open access
PDF file
FGFrank L. Greenway
Frank L. Greenway
MWM.J. Whitehouse
M.J. Whitehouse
MGMaria Guttadauria
Maria Guttadauria
JAJames W. Anderson
James W. Anderson
RARichard L. Atkinson
Richard L. Atkinson
MCMichael A. Cowley
Michael A. Cowley
Existing obesity therapies are limited by safety concerns and modest efficacy reflecting a weight loss plateau. Here, we explore combination therapy with bupropion (BUP), a putative stimulator of melanocortin pathways, and an opioid antagonist, naltrexone (NAL), to antagonize an inhibitory feedback loop that limits sustained weight reduction. In vitro electrophysiologic experiments were conducted to determine the extent to which BUP+NAL stimulated hypothalamic pro‐opiomelanocortin (POMC) neurons in mouse brain. A subsequent study further characterized the effect of combination BUP+NAL treatment on food intake in lean and obese mice. Finally, a randomized, blinded, placebo‐controlled trial in obese adult subjects was conducted. Randomization included: BUP (300 mg) + NAL (50 mg), BUP (300 mg) + placebo (P), NAL (50 mg) + P or P+P for up to 24 weeks. BUP+NAL stimulated murine POMC neurons in vitro and caused a greater reduction in acute food intake than either monotherapy, an effect consistent with synergism. Combined BUP+NAL provided sustained weight loss without evidence of an efficacy plateau through 24 weeks of treatment. BUP+NAL completers diverged from NAL+P (P < 0.01) and P+P (P < 0.001) at week 16 and from BUP+P by week 24 (P < 0.05). The combination was also well tolerated. Translational studies indicated that BUP+NAL therapy produced synergistic weight loss which exceeded either BUP or NAL alone. These results supported the hypothesis that NAL, through blockade of β‐endorphin mediated POMC autoinhibition, prevents the classic weight loss plateau observed with monotherapies such as BUP. This novel treatment approach (BUP+NAL) holds promise for the treatment of obesity.

25 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Stephanie BroylesStephanie Broyles
Stephanie Broyles
Amanda StaianoAmanda Staiano
Amanda Staiano
KDKathryn T. Drazba
Kathryn T. Drazba
AGAlok K. Gupta
Alok K. Gupta
MSMelinda Sothern
Melinda Sothern
PKPeter Katzmarzyk
Peter Katzmarzyk
Childhood socioeconomic status is linked to adult cardiovascular disease and disease risk. One proposed pathway involves inflammation due to exposure to a stress-inducing neighborhood environment. Whether CRP, a marker of systemic inflammation, is associated with stressful neighborhood conditions among children is unknown. The sample included 385 children 5–18 years of age from 255 households and 101 census tracts. Multilevel logistic regression analyses compared children and adolescents with CRP levels >3 mg/L to those with levels ≤3 mg/L across neighborhood environments. Among children living in neighborhoods (census tracts) in the upper tertile of poverty or crime, 18.6% had elevated CRP levels, in contrast to 7.9% of children living in neighborhoods with lower levels of poverty and crime. Children from neighborhoods with the highest levels of either crime or poverty had 2.7 (95% CI: 1.2–6.2) times the odds of having elevated CRP levels when compared to children from other neighborhoods, independent of adiposity, demographic and behavioral differences. Children living in neighborhoods with high levels of poverty or crime had elevated CRP levels compared to children from other neighborhoods. This result is consistent with a psychosocial pathway favoring early development of cardiovascular risk that involves chronic stress from exposure to socially- and physically-disordered neighborhoods characteristic of poverty.

1 December 2011 in Obesity
Verified
Journal Article
Closed access
PDF file
EHEd J. Hendricks
Ed J. Hendricks
FGFrank L. Greenway
Frank L. Greenway
EWEric C. Westman
Eric C. Westman
AGAlok K. Gupta
Alok K. Gupta

10 June 2010 in Hypertension Research
Verified
Journal Article
Closed access
AGAlok K Gupta
Alok K Gupta
MMMeghan McGlone
Meghan McGlone
FGFrank L Greenway
Frank L Greenway
WJWilliam D Johnson
William D Johnson

1 April 2011 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
SBSudip Bajpeyi
Sudip Bajpeyi
MPMagdalena Pasarica
Magdalena Pasarica
CMCedric Moro
Cedric Moro
KCKevin Conley
Kevin Conley
SJSharon Jubrias
Sharon Jubrias
SSSteven R. Smith
Steven R. Smith
Objective: The objective of this study was to determine the role of maximum mitochondrial capacity on the variation in insulin sensitivity within a population of patients with type 2 diabetes mellitus (T2DM). Research Design and Methods: Fifty-eight participants enrolled in a cross-sectional design: eight active controls [maximum aerobic capacity (VO2max) > 40 ml/kg · min], 17 healthy sedentary controls without a family history (FH−) and seven with a family history (FH+) of diabetes, four obese participants, and 21 patients with T2DM. Mitochondrial capacity was measured noninvasively using 31P magnetic resonance spectroscopy of the vastus lateralis. Maximal ATP synthetic rate (ATPmax) was determined from the rate of phosphocreatine (PCr) recovery after short-term isometric exercise. Results: ATPmax was lower (P < 0.001) in T2DM and higher (P < 0.001) in active as compared with healthy sedentary FH− (active, 1.01 ± 0.2; FH−, 0.7 ± 0.2; FH+, 0.6 ± 0.1; obese, 0.6 ± 0.1; T2DM, 0.5 ± 0.2 mm ATP/sec; ANOVA P < 0.0001). Insulin sensitivity, measured by euglycemic-hyperinsulinemic (80 mIU/m2 · min) clamp was also reduced in T2DM (P < 0.001) (active, 12.0 ± 3.2; FH−, 7.8 ± 2.2; FH+, 6.8 ± 3.5; obese, 3.1 ± 1.0; T2DM, 3.4 ± 1.6; mg/kg estimated metabolic body size · min; ANOVA P < 0.0001). Unexpectedly, there was a broad range of ATPmax within the T2DM population where 52% of subjects with T2DM had ATPmax values that were within the range observed in healthy sedentary controls. In addition, 24% of the T2DM subjects overlapped with the active control group (range, 0.65–1.27 mm ATP/sec). In contrast to the positive correlation between ATPmax and M-value in the whole population (r2 = 0.35; P < 0.0001), there was no correlation between ATPmax and M-value in the patients with T2DM (r2 = 0.004; P = 0.79). Conclusions: Mitochondrial capacity is not associated with insulin action in T2DM.

1 February 2011 in Acta Cardiologica
Verified
Journal Article
Closed access
RSRam B. Singh
Ram B. Singh
JFJan Fedacko
Jan Fedacko
DPDaniel Pella
Daniel Pella
ZMZelmira Macejova
Zelmira Macejova
SGSaraswati Ghosh
Saraswati Ghosh
AGAlok K. Gupta
Alok K. Gupta
Background There are few studies detailing the prevalence of prehypertension and hypertension in India. Methods Men and women, over 25 years of age were included. After completion of a dietitian-administered questionnaire followed evaluation by a physician, physical examination and blood pressure measurement. Cross-sectional survey screened 6940 subjects, (3507 men (M), 3433 women (W): 1993-96) from cities located in five corners of India (Kolkata, n = 900; Nagpur, n = 894; Mumbai, n = 1542; Thiruanantpuram, n = 1602; Moradabad, n = 2002). Prehypertension (BP 130-139/85-89 mm Hg) and hypertension (BP ≥ 140/90 mm Hg) were diagnosed according to the European Society of Cardiology criteria. Results Prevalence of prehypertension and hypertension, respectively, was significantly greater in South India (Trivandrum: W 31.5; 31.9%; M 35.1; 35.5%) and West India (Mumbai: W 30.0; 29.1%; M 34.7; 35.6%) compared to North India (Moradabad: W 24.6; 24.5%; M 26.7; 27.0%) and East India (Kolkata: W 20.9; 22.4%; M 23.5; 24.0%). Subjects with prehypertension and hypertension were older, had a higher BMI, central obesity and a sedentary lifestyle. They had a higher salt and alcohol intake, with greater oral contraceptive usage (W). Multivariable logistic regression analysis revealed strong positive associations of hypertension with age, central obesity, BMI, sedentary lifestyle, salt and alcohol intake and oral contraceptive usage (W). Fruit, vegetable and legume intake showed inverse associations, tobacco intake showed none. One in four with hypertension was aware of their diagnosis and of those receiving treatment, one in three had well-controlled hypertension. Conclusions There is little awareness that prehypertension and hypertension are public health issues in India. Ageing population, central obesity, sedentary lifestyle, excessive salt and alcohol, lower fruit, vegetable and legumes intake increase risk for blood pressure elevation.